Clinical Research

For more information about current and future trials/studies, contact Brenda Wear at bwear@premiersurgical.com or 865-862-6929.

 

Current Trials/Studies

DEFINITIVE Ca++: Study of the SilverHawk/TurboHawk Plaque Excision Systems Used With SpiderFX to Treat Calcified Peripheral Arterial Disease

This is a multi-center, non-randomized, single arm study of the SilverHawk/TurboHawk plaque excision systems when used in conjunction with SpiderFX in treatment of moderate to severely calcified peripheral arterial disease in the superficial femoral and/or popliteal arteries.

Principal Investigator

• Christopher W. Pollock, MD, FACS

Sub Investigators

• C. Scott Callicutt, MD
• Willard B. Campbell, MD, FACS

Enrollment Location

• Parkwest Medical Center

For More Information

MOBILITY: Trial to Evaluate the Safety & Efficacy of the Absolute ProTM Peripheral Self-Expanding Stent System and Omnilink EliteTM Peripheral Balloon-Expandable Stent System

This trial is designed to determine the safety and efficacy of the absolute pro peripheral self-expanding stent systems in subjects with atherosclerotic de novo or re stenotic lesions in the native common iliac artery.

Principal Investigator

• George A. Pliagas, MD, FACS

Sub Investigators

• Donald L. Akers Jr., MD, FACS
• C. Scott Callicutt, MD
• Willard B. Campbell, MD, FACS
• Christopher W. Pollock, MD, FACS

Enrollment Location

• Mercy Medical Center St. Mary's
• Parkwest Medical Center

For More Information

DURABILITY II: Safety and Effectiveness Study of EverFlex Stent to Treat Symptomatic Femoral-popliteal Atherosclerosis

DURABILITY II is a U.S. study evaluating endovascular lesions in the superficial femoral artery and proximal popliteal by using the PROTÉGÉ EverFlex Nitional Stent System II.

Principal Investigator

• Christopher W. Pollock, MD, FACS

Sub Investigators

• Donald L. Akers Jr., MD, FACS
• C. Scott Callicutt, MD
• Willard B. Campbell, MD, FACS

Enrollment Location

• Parkwest Medical Center (This study is no longer enrolling patients.)

For More Information

CHOICE: Carotid Stenting For High Surgical-risk Patients

CHOICE Registry for Carotid Stent for high surgical risk patients. Evaluates outcomes through the collection of clinical evidence.

Principal Investigator

• Christopher W. Pollock, MD, FACS

Sub Investigator

• C. Scott Callicutt, MD

Enrollment Location

• Parkwest Medical Center

Future Enrollment Location

• Mercy Medical Center St. Mary's

For More Information

VITALITY: Post-Approval Trial of the Talent^TM Abdominal Stent Graft to Treat Aortic Aneurysms

VITALITY abdominal aortic aneurysm repair is a post-approval study using the Medtronic Talent Graft System evaluating the performance of the Talent Abdominal Stent Graft system in the post-approval environment.

Principal Investigator

• George A. Pliagas, MD, FACS

Sub Investigators

• Christopher W. Pollock, MD, FACS
• Donald L. Akers Jr., MD, FACS
• Willard B. Campbell, MD, FACS

Enrollment Location

• Mercy Medical Center St. Mary's (This study is no longer enrolling patients.)

For More Information

 

Future Trials/Studies

THRIVE: Post-Approval Clinical Study of the Talent Thoracic Stent Graft to Treat Thoracic Aortic Aneurysms

Endovascular repair of descending thoracic aneurysms using the Talent Thoracic Stent Graft System.

Principal Investigator

• George A. Pliagas, MD, FACS

Sub Investigators

• Donald L. Akers Jr., MD, FACS
• C. Scott Callicutt, MD

Enrollment Location

• Mercy Medical Center St. Mary's

For More Information